Melodi Matrix™ in Breast Reconstruction

Part of paid clinical trials in Palo Alto, California.

Sponsor
Melodi Health, Inc.
Study ID
NCT06027996
Status
Recruiting

Conditions

  • Breast Reconstruction

Eligibility Criteria

Sex
FEMALE
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Absorbable Antibacterial Matrix — DEVICE
    Soft tissue support coated with antibiotics

Study Details

Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage prepectoral alloplastic breast reconstruction.

Key Dates

Start date
Aug 9, 2024
Status verified
Dec 2025
Primary completion
Dec 31, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
702 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Treatment
    Tissue expander implantation with the Melodi Matrix
  • No Intervention: Control
    Tissue expander implantation without a matrix

Primary Outcome Measure

Complications of Breast Reconstruction [ Time Frame: 6 months ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Stanford UniversityPalo AltoCalifornia94304
Elizabeth Tadevosyan
818-269-1950
University of Michigan HealthAnn ArborMichigan48109
Jenni Hamill
507-559-7912
Mayo ClinicRochesterMinnesota55905
Amy Holst
507-538-4849
Northwell HealthStaten IslandNew York10305
Shannen Ballotte
718-226-8559
The Ohio State UniversityColumbusOhio43212
Jenna King
614-293-7551
UPMCPittsburghPennsylvania15213
Eleanor Shirley
412-624-2376
Medical University of South CarolinaCharlestonSouth Carolina29425
Deanna DeHoff
843-792-8522
Monument HealthRapid CitySouth Dakota57701
Angie Dunbar
605-755-2370
MD Anderson Cancer CenterHoustonTexas77030
Sara Hull
832-499-6321
University of UtahSalt Lake CityUtah84112
Martin Carricaburu
801-581-3363

Find similar trials in Palo Alto, CA

Related Studies